WellCare president in Kentucky after cancer: 'It's real hard to depress me'

A chest muscle injury was what originally sent Bill Jones to his doctor's office. What the doctor found in what was supposed to be a routine CT scan would alter the path of his career. "They said it was a stage-one tumor … and that I was the luckiest man in the man in the world," Jones said. Doctors removed a roughly 1-inch cancerous tumor from his kidney. Jones said he was lucky because the doctors had found the cancer early. In August, he will celebrate 10 years of being can cer-free. Now, Jones…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news

Related Links:

AbstractBackgroundRoughly 23% of breast conserving surgery (BCS) patients undergo a second re-excision procedure due to pathologically positive surgical margins. We investigated the feasibility and potential value of micro-Computed Tomography (micro-CT) as a surgical margin guidance tool during BCS.MethodsA cohort of 32 BCS specimens was prospectively imaged with a pre-clinical micro-CT system upon arrival in the surgical pathology laboratory. Reconstructed micro-CT scans were evaluated retrospectively by an experienced breast radiologist, who provided binary determinations whether lesions extended to the specimen margin. ...
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
Authors: Sarikaya I, Sarikaya A Abstract Objective: Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) has limited value in early breast cancer. Sentinel lymph node (SLN) biopsy is the current procedure of choice to search for small metastatic deposits in the axillary lymph nodes in early breast cancer. In this retrospective study, we re-evaluated 18F-FDG PET/CT images after locating SLN(s) on PET/CT with the help of SLN single photon emission computed tomography/computed tomography (SPECT/CT) images and assessed 18F-FDG uptake particularly in the SLN(s). Our goal was...
Source: Journal of Nuclear Medicine Technology - Category: Nuclear Medicine Tags: J Nucl Med Technol Source Type: research
Conclusion Binimetinib was well tolerated and showed promising evidence of activity in patients with BTC. Correlative studies suggested the potential for binimetinib to promote muscle gain in patients with BTC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 10 November 2018Source: Academic RadiologyAuthor(s): Kenny H. Cha, Lubomir M. Hadjiiski, PhD, Richard H. Cohan, MD, Heang-Ping Chan, PhD, Elaine M. Caoili, MD, Matthew Davenport, MD, Ravi K. Samala, PhD, Alon Z. Weizer, MD, Ajjai Alva, MD, Galina Kirova-Nedyalkova, MD, PhD, Kimberly Shampain, MD, Nathaniel Meyer, MD, Daniel Barkmeier, MD, PhD, Sean Woolen, MD, Prasad R. Shankar, MD, Isaac R. Francis, MD, Phillip Palmbos, MDRationale and ObjectivesTo evaluate whether a computed tomography (CT)-based computerized decision-support system for muscle-invasive bladder cancer treatment response ...
Source: Academic Radiology - Category: Radiology Source Type: research
CONCLUSION: The semi-quantitative analysis of 18F-FDG PET/CT has an important role in MPM therapy response assessment and has a predictive role in distinguishing responders and non-responders. PMID: 30411729 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
AbstractPurpose of ReviewDetermining the metastatic viability of suspicious retroperitoneal nodes in testicular cancer with conventional imaging is challenging. The aim of this report is to review recent evidence in the utilization of novel imaging modalities to assess viable testicular cancer nodal metastases.Recent EvidenceTesticular germ cell tumors (TCGTs) follow a predictable lymphatic metastatic spread to the retroperitoneum. Accordingly, retroperitoneal imaging is critical in staging, assessing treatment response, and evaluating for recurrence. Conventional computed tomography (CT) imaging is effective in diagnosing...
Source: Current Urology Reports - Category: Urology & Nephrology Source Type: research
CONCLUSION: At MBC-11 doses that were well tolerated, substantial reductions in metabolic activity of bone-associated cancer cells provide a foundation for further disease-directed efficacy studies. PMID: 30413669 [PubMed - as supplied by publisher]
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Oncologist Source Type: research
About one in fifty people reading this essay will be diagnosed with kidney cancer at some time in their life. In fact, one out of one people  writing this essay has already been diagnosed with kidney cancer. (I had a small tumor removed from my left kidney not long after I turned 50.) But how many people […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Conditions Nephrology Oncology/Hematology Source Type: blogs
68Gallium-DOTATATE positron emission tomography –computed tomography (PET CT) has shown superior accuracy in detecting grade 1 and 2 neuroendocrine tumors over previous imaging modalities and was recently included in National Comprehensive Cancer Network guidelines. It remains unclear which patients benefit most from this imaging modality. We t herefore reviewed our initial experience with 68Gallium-DOTATATE PET CT to evaluate its usefulness in diagnosing, staging, and surveilling neuroendocrine tumors.
Source: Surgery - Category: Surgery Authors: Source Type: research
CONCLUSIONS: Specific testing for cancer in people with unprovoked VTE may lead to earlier diagnosis of cancer at an earlier stage of the disease. However, there is currently insufficient evidence to draw definitive conclusions concerning the effectiveness of testing for undiagnosed cancer in people with a first episode of unprovoked VTE (DVT or PE) in reducing cancer- or VTE-related morbidity and mortality. The results could be consistent with either benefit or no benefit. Further good-quality large-scale randomised controlled trials are required before firm conclusions can be made. PMID: 30407621 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Tags: Cochrane Database Syst Rev Source Type: research
More News: American Health | Cancer | Cancer & Oncology | CT Scan | Health Management | PET Scan | Urology & Nephrology